Zydus Lifesciences Limited has announced the appointment of M/s. Walker Chandiok & Co LLP as its new statutory auditors. This decision follows the completion of the second consecutive five-year term by the current auditors, Deloitte Haskins and Sells LLP, at the conclusion of the 32nd Annual General Meeting for the financial year 2026-2027. The appointment of Walker Chandiok & Co LLP is for a term of five years, subject to shareholder approval.
Auditor Rotation at Zydus Lifesciences
Zydus Lifesciences Limited has initiated a change in its statutory auditors due to mandatory auditor rotation regulations. The current auditors, Deloitte Haskins and Sells LLP, will conclude their second consecutive five-year term following the 32nd Annual General Meeting (AGM) for the financial year 2026-2027. This transition aligns with the requirements stipulated under section 139(2) of the Companies Act, 2013.
Appointment of New Auditors
Following the recommendation of the Audit Committee, the Board of Directors approved the appointment of M/s. Walker Chandiok & Co LLP, Chartered Accountants, as the new statutory auditors. This appointment is for an initial term of five years, commencing from the conclusion of the 32nd AGM for the financial year 2026-2027 and extending through the 37th AGM for the financial year 2031-2032. The appointment is subject to the approval of the company’s members at the upcoming 32nd AGM.
About Walker Chandiok & Co LLP
M/s. Walker Chandiok & Co LLP is a member firm of Grant Thornton International and is registered with the Institute of Chartered Accountants of India (ICAI). Established in 1935, the firm has a rich history spanning over 90 years and operates with a registered office in New Delhi, complemented by nineteen offices across major Indian cities. It boasts ninety-nine partners and holds a valid peer review certificate. The firm is recognized as a leading audit firm in India, providing audit and assurance services to numerous large companies, including many top-tier listed entities. They have significant experience in serving the pharmaceuticals and healthcare sectors, supported by multidisciplinary teams specializing in audit, tax, technology, and industry expertise.
Source: BSE
